Catharig, Lee May .

HRN: 28-08-64  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2026
CO-AMOXICLAV 625MG (TAB)
02/06/2026
02/12/2026
PO
1tab
Bid
Nsvd
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: